Shuichiro Nakabo

Shuichiro Nakabo

Auto-generated profile, based on publicly available information

Shuichiro Nakabo

Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University , Kyoto

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2020 in New England Journal of Medicine
Verified
Journal Article
Closed access
DBDavid B. Beck
David B. Beck
MFMarcela A. Ferrada
Marcela A. Ferrada
KSKeith A. Sikora
Keith A. Sikora
AOAmanda K. Ombrello
Amanda K. Ombrello
JCJason C. Collins
Jason C. Collins
PGPeter C. Grayson
Peter C. Grayson
Adult-onset inflammatory syndromes often manifest with overlapping clinical features. Variants in ubiquitin-related genes, previously implicated in autoinflammatory disease, may define new disorders.

29 June 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SGSarthak Gupta
Sarthak Gupta
SNShuichiro Nakabo
Shuichiro Nakabo
LBLuz P. Blanco
Luz P. Blanco
LOLiam J. O’nEil
Liam J. O’nEil
GWGustaf Wigerblad
Gustaf Wigerblad
MKMariana J. Kaplan
Mariana J. Kaplan
Significance: Despite clear differences in female and male immunity that may contribute to variations in response to infections and predisposition to cancer and autoimmunity, the exact mechanisms that drive this stark contrast remain insufficiently characterized. Neutrophils play essential roles in homeostasis and disease, but little is known about how sex differences modulate their phenotype and function. Using transcriptomic and functional approaches, we report that healthy young adult females have an activated/mature neutrophil profile characterized by enhanced type I IFN pathway activity, enhanced proinflammatory responses, and distinct bioenergetics. We further show that these differences are cell specific and likely driven by sex hormones. Modulation of these pathways in neutrophils may provide more individualized, sex-specific therapeutic options in a variety of disease states.

25 April 2019 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
JMJulio E. Molineros
Julio E. Molineros
LLLoren L. Looger
Loren L. Looger
KKKwangwoo Kim
Kwangwoo Kim
YOYukinori Okada
Yukinori Okada
CTChikashi Terao
Chikashi Terao
SNSwapan K. Nath
Swapan K. Nath
Human leukocyte antigen (HLA) is a key genetic factor conferring risk of systemic lupus erythematosus (SLE), but precise independent localization of HLA effects is extremely challenging. As a result, the contribution of specific HLA alleles and amino-acid residues to the overall risk of SLE and to risk of specific autoantibodies are far from completely understood. Here, we dissected (a) overall SLE association signals across HLA, (b) HLA-peptide interaction, and (c) residue-autoantibody association. Classical alleles, SNPs, and amino-acid residues of eight HLA genes were imputed across 4,915 SLE cases and 13,513 controls from Eastern Asia. We performed association followed by conditional analysis across HLA, assessing both overall SLE risk and risk of autoantibody production. DR15 alleles HLA-DRB1*15:01 (P = 1.4x10-27, odds ratio (OR) = 1.57) and HLA-DQB1*06:02 (P = 7.4x10-23, OR = 1.55) formed the most significant haplotype (OR = 2.33). Conditioned protein-residue signals were stronger than allele signals and mapped predominantly to HLA-DRB1 residue 13 (P = 2.2x10-75) and its proxy position 11 (P = 1.1x10-67), followed by HLA-DRB1-37 (P = 4.5x10-24). After conditioning on HLA-DRB1, novel associations at HLA-A-70 (P = 1.4x10-8), HLA-DPB1-35 (P = 9.0x10-16), HLA-DQB1-37 (P = 2.7x10-14), and HLA-B-9 (P = 6.5x10-15) emerged. Together, these seven residues increased the proportion of explained heritability due to HLA to 2.6%. Risk residues for both overall disease and hallmark autoantibodies (i.e., nRNP: DRB1-11, P = 2.0x10-14; DRB1-13, P = 2.9x10-13; DRB1-30, P = 3.9x10-14) localized to the peptide-binding groove of HLA-DRB1. Enrichment for specific amino-acid characteristics in the peptide-binding groove correlated with overall SLE risk and with autoantibody presence. Risk residues were in primarily negatively charged side-chains, in contrast with rheumatoid arthritis. We identified novel SLE signals in HLA Class I loci (HLA-A, HLA-B), and localized primary Class II signals to five residues in HLA-DRB1, HLA-DPB1, and HLA-DQB1. These findings provide insights about the mechanisms by which the risk residues interact with each other to produce autoantibodies and are involved in SLE pathophysiology. The Human leukocyte antigen (HLA) region is a key genetic factor conferring risk of systemic lupus erythematosus (SLE). In spite of multiple SLE association signals identified in the HLA region, only amino-acid residues within HLA-DRB1 have been specifically described previously. In this study, we performed an imputation-based analysis on individuals with East Asian ancestry, and characterized SLE risk within the HLA region for all involved independent genes (HLA-DRB1, HLA-DPB1, HLA-DQB1, HLA-A, and HLA-B). Furthermore, we identified a characteristic SLE risk residue signature as well as a pattern of specific nRNP and Ro/La autoantibody residues located in the peptide-binding grooves, suggesting their key involvement in autoantibody production.

12 April 2024 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
HOHirotsugu Hirotsugu Oda
Hirotsugu Hirotsugu Oda
KMKalpana Manthiram
Kalpana Manthiram
PCPallavi Pimpale Chavan
Pallavi Pimpale Chavan
EREva Rieser
Eva Rieser
ÖVÖnay Veli
Önay Veli
DKDaniel L. Kastner
Daniel L. Kastner

1 March 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
SNShuichiro Nakabo
Shuichiro Nakabo
JRJorge Romo-Tena
Jorge Romo-Tena
MKMariana J. Kaplan
Mariana J. Kaplan

2 May 2019 in Modern Rheumatology
Verified
Journal Article
Closed access
SNShuichiro Nakabo
Shuichiro Nakabo
KOKoichiro Ohmura
Koichiro Ohmura
SAShuji Akizuki
Shuji Akizuki
KMKosaku Murakami
Kosaku Murakami
RNRan Nakashima
Ran Nakashima
TMTsuneyo Mimori
Tsuneyo Mimori
Objective: An anti-carbamylated albumin antibody was detected in rheumatoid arthritis (RA) patients, and its presence was associated with serum myeloperoxidase (MPO) levels, as we reported previously. Since MPO is a key enzyme for carbamylation and is released by neutrophil extracellular traps (NETs), we aimed to demonstrate that NETosis induces carbamylation. Methods: Human neutrophils were isolated from a healthy donor, pre-treated with or without diphenyleneiodonium (DPI, an inhibitor for the generation of reactive oxygen species (ROS)), Cl-amidine (a peptidylarginine deiminase inhibitor), 4-aminobenzoic acid hydrazide (4-ABAH, an MPO inhibitor), or GW311616A (a neutrophil elastase (NE) inhibitor), and incubated for 8 h with or without phorbol 12-myristate 13-acetate (PMA). Proteins in the medium were collected and the carbamylation of albumin was evaluated by Western blotting. Results: The carbamylation of albumin was detected in the culture medium of activated neutrophils. NETosis was observed under the stimulation by PMA. DPI and 4-ABAH inhibited the carbamylation of albumin and NETosis. GW311616A inhibited NETosis, but not carbamylation. Neither carbamylation nor NETosis was inhibited by Cl-amidine. Conclusion: Activated neutrophils may carbamylate ambient albumin, and this is dependent on ROS and MPO, but does not require NETosis.